We are a multidisciplinary team focused on improving the lives of cancer patients

We combine approaches from biology, engineering, neuroscience, and drug delivery to design novel cancer diagnostics and therapeutics

Check out our recent feature in the Eshelman Institute for Innovation Featured News about our novel diagnostic platform using brain slices, pioneered by Dr. Andrew Satterlee and our brain slice team members!

What we do:

Developing novel ex vivo tumor models using live animal tissue

Enhancing neural stem cells as anti-cancer therapeutics

Optimizing the delivery of cell therapies using biomaterial matrices